Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C W Burger

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
European Journal of Cancer (Oxford, England : 1990)|November 1, 2002
Loss of progesterone receptor may lead to an invasive phenotype in human endometrial cancerE E Hanekamp, E C M Kühne, E Smid-Koopman, et al.
The Journal of Clinical Endocrinology and Metabolism|May 3, 2003
Progestogenic effects of tibolone on human endometrial cancer cellsL J Blok, P E De Ruiter, E C M Kühne, et al.
The Journal of Clinical Endocrinology and Metabolism|December 2, 2004
Molecular portrait of the progestagenic and estrogenic actions of tibolone: behavior of cellular networks in response to tiboloneP Hanifi-Moghaddam, S C J P Gielen, H J Kloosterboer, et al.
Journal of Molecular Medicine (Berlin, Germany)|January 18, 2007
Molecular analysis of human endometrium: short-term tibolone signaling differs significantly from estrogen and estrogen + progestagen signalingP Hanifi-Moghaddam, B Boers-Sijmons, A H A Klaassens, et al.
Human Reproduction (Oxford, England)|July 13, 2012
Factors associated with dizygotic twinning after IVF treatment with double embryo transferE Groeneveld, M J Lambers, M E F Stakelbeek, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2014
Increased breast cancer risk in in vitro fertilisation treated women with a multiple pregnancy: a new hypothesis based on historical in vitro fertilisation treatment dataI M Krul, E Groeneveld, M Spaan, et al.
European Journal of Cancer (Oxford, England : 1990)|February 20, 2007
Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer casesC T M Brekelmans, M M A Tilanus-Linthorst, C Seynaeve, et al.
British Journal of Cancer|April 12, 2007
No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up studyB B J Hermsen, R I Olivier, R H M Verheijen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 2, 2013
Outcome of BRCA1- compared with BRCA2-associated ovarian cancer: a nationwide study in the NetherlandsP M L H Vencken, W Reitsma, M Kriege, et al.
Human Reproduction (Oxford, England)|October 28, 2011
Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohortF E van Leeuwen, H Klip, T M Mooij, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
European Journal of Cancer (Oxford, England : 1990)|November 1, 2002
Loss of progesterone receptor may lead to an invasive phenotype in human endometrial cancerE E Hanekamp, E C M Kühne, E Smid-Koopman, et al.
The Journal of Clinical Endocrinology and Metabolism|May 3, 2003
Progestogenic effects of tibolone on human endometrial cancer cellsL J Blok, P E De Ruiter, E C M Kühne, et al.
The Journal of Clinical Endocrinology and Metabolism|December 2, 2004
Molecular portrait of the progestagenic and estrogenic actions of tibolone: behavior of cellular networks in response to tiboloneP Hanifi-Moghaddam, S C J P Gielen, H J Kloosterboer, et al.
Journal of Molecular Medicine (Berlin, Germany)|January 18, 2007
Molecular analysis of human endometrium: short-term tibolone signaling differs significantly from estrogen and estrogen + progestagen signalingP Hanifi-Moghaddam, B Boers-Sijmons, A H A Klaassens, et al.
Human Reproduction (Oxford, England)|July 13, 2012
Factors associated with dizygotic twinning after IVF treatment with double embryo transferE Groeneveld, M J Lambers, M E F Stakelbeek, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2014
Increased breast cancer risk in in vitro fertilisation treated women with a multiple pregnancy: a new hypothesis based on historical in vitro fertilisation treatment dataI M Krul, E Groeneveld, M Spaan, et al.
European Journal of Cancer (Oxford, England : 1990)|February 20, 2007
Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer casesC T M Brekelmans, M M A Tilanus-Linthorst, C Seynaeve, et al.
British Journal of Cancer|April 12, 2007
No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up studyB B J Hermsen, R I Olivier, R H M Verheijen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 2, 2013
Outcome of BRCA1- compared with BRCA2-associated ovarian cancer: a nationwide study in the NetherlandsP M L H Vencken, W Reitsma, M Kriege, et al.
Human Reproduction (Oxford, England)|October 28, 2011
Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohortF E van Leeuwen, H Klip, T M Mooij, et al.
Pageof 9